Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page
- Check4 days agoChange DetectedAdded Naples, Italy, 80131 as a trial site. Removed Napoli, Italy, 80131 and Melanoma and MedlinePlus Genetics-related topics from the related topics section.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check18 days agoChange DetectedMelanoma and related topics, including MedlinePlus Genetics, were added; the page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check25 days agoChange DetectedMelanoma content and the MedlinePlus Genetics related topics were removed from the page.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded Melanoma topic, MedlinePlus Genetics link, and a new JAMA Netw Open citation related to adjuvant pembrolizumab in melanoma.SummaryDifference0.1%

- Check47 days agoChange DetectedA new site revision label, v3.4.2, was added and an older revision (v3.4.1) along with some topic tags (Melanoma, MedlinePlus Genetics, related topics) were removed. These appear to be administrative updates to the page's metadata.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.